Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
News
Migraine comorbidities rise with increased headache days
- Author:
- Mitchel L. Zoler, PhD
Publish date: July 12, 2019
News

Drug efficacy in phase 2 RA trials often missing in phase 3
- Author:
- Mitchel L. Zoler, PhD
Publish date: July 9, 2019
News
FDA warning letters fall on Trump’s watch
- Author:
- Mitchel L. Zoler, PhD
Publish date: July 2, 2019
News

EULAR keeps csDMARDs as top PsA drugs
- Author:
- Mitchel L. Zoler, PhD
Publish date: July 1, 2019
News
Infections linked with transition to psoriatic arthritis
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 28, 2019
News
Revised CMS TAVR rules expected to widen access
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 25, 2019
News

Imaging remission decried as ticket to RA overtreatment
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 24, 2019
News
EULAR revises its RA management recommendations
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 21, 2019
News
Ixekizumab surpasses adalimumab in PsA head-to-head study
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 16, 2019
Video

Cardiovascular events in U.S. RA patients fall to non-RA level
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 15, 2019
Video

Lowering hyperuricemia improved endothelial function but failed as an antihypertensive
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 14, 2019
News
Tofacitinib shows safety during real-world RA use
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 13, 2019
News

Pivotal trial shows HFrEF benefits from baroreceptor stimulation
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 11, 2019
News
Updated systematic review of aspirin primary prevention shows benefits, risks
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 10, 2019
News

DOACs surpass warfarin in low-weight AFib patients
- Author:
- Mitchel L. Zoler, PhD
Publish date: June 5, 2019